My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

8.620 +1.250 (+16.96%)

Streaming Delayed Price Updated: 10:38 AM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Karyopharm Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom ↗

May 23, 2024

These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress.

Via InvestorPlace

Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript ↗

May 08, 2024

KPTI earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

KPTI Stock Earnings: Karyopharm Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗

May 08, 2024

KPTI stock results show that Karyopharm Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript ↗

February 29, 2024

KPTI earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Karyopharm Therapeutics's Earnings: A Preview ↗

February 28, 2024

Via Benzinga

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory ↗

February 25, 2024

Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.

Via InvestorPlace

Earnings Preview For Karyopharm Therapeutics ↗

November 01, 2023

Via Benzinga

6 Analysts Have This to Say About Karyopharm Therapeutics ↗

August 03, 2023

Via Benzinga

4 Analysts Have This to Say About Karyopharm Therapeutics ↗

July 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 31, 2024

Via Benzinga

Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript ↗

November 02, 2023

KPTI earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Stocks That Hit 52-Week Lows On Wednesday ↗

August 30, 2023

On Wednesday, 59 companies achieved new lows for the year.

Via Benzinga

Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript ↗

August 02, 2023

KPTI earnings call for the period ending June 30, 2023.

Via The Motley Fool

Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain Mutation ↗

July 26, 2023

Karyopharm Therapeutics Inc (NASDAQ: KPTI) announced the presentation of updated exploratory subgroup analyses from the SIENDO study in patients with advanced or recurrent TP53 wild-type endometrial...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 18, 2023

During Tuesday's trading, 46 companies set new 52-week lows.

Via Benzinga

CMG Stock Alert: Chipotle Announces International Expansion Plan ↗

July 18, 2023

Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion.

Via InvestorPlace

Why Are Karyopharm Therapeutics Shares Gaining Today? ↗

July 18, 2023

Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares are trading higher after the FDA granted Fast Track Designation to the development program of selinexor for myelofibrosis, including primary...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 18, 2023

Via Benzinga

Why Is CEL-SCI (CVM) Stock Down 23% Today? ↗

July 18, 2023

CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.

Via InvestorPlace

Why Is Masimo (MASI) Stock Down 30% Today? ↗

July 18, 2023

Masimo (MASI) stock is taking a beating on Tuesday after the patient monitoring tech company released preliminary earnings for Q2 2023.

Via InvestorPlace

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗

July 18, 2023

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's...

Via Benzinga

Why Is Karyopharm Therapeutics (KPTI) Stock Up 21% Today? ↗

July 18, 2023

Karyopharm Therapeutics (KPTI) stock is climbing higher on Tuesday after getting fast-track designation for its myelofibrosis treatment.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 18, 2023

It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 17, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 05, 2023

Wednesday's session saw 43 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 16, 2023

Friday's session saw 32 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition